New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 6, 2013
06:13 EDTVASCVascular Solutions downgraded to Hold from Buy at Benchmark Co.
Benchmark Co. downgraded Vascular Solutions citing valuation following the company's Q4 results. The firm keeps a $17 price target for shares.
News For VASC From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
January 28, 2015
08:21 EDTVASCVascular Solutions to purchase additional manufacturing facility for $2.7M
Vascular Solutions announced that it has entered into an agreement to acquire a 26,000-square-foot building located at 6420 Sycamore Court North in Maple Grove, Minnesota. The purchase price will be $2.7M and funded with existing cash. The closing is expected to take place in early March, subject to customary closing conditions. The building is located across the street from Vascular Solutions' existing manufacturing facility and headquarters building. The newly-acquired facility will be used initially for the company's component manufacturing operations, with future use planned for the commercial scale production of freeze-dried plasma which is being developed in collaboration with the United States Army. Upon closing of the acquisition, Vascular Solutions intends to occupy approximately 17,500 square feet of the building, with an existing tenant expected to continue to occupy the remaining 8,500 square feet.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use